May 2 (Reuters) - CSL Ltd (CSL) :
- DUPLEX STUDY DID NOT ACHIEVE PRIMARY EFFICACY EGFR SLOPE ENDPOINT OVER 108 WEEKS OF TREATMENT
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$264.98 |
Change
1.030(0.39%) |
Mkt cap ! $128.6B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $265.88 | $259.33 | $134.7M | 511.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 158 | $264.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $264.99 | 27 | 8 |
View Market Depth
| Last trade - 15.26pm 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |